WPD Pharmaceuticals Inc (WBIO)

0.0650
-0.0200(-23.53%)
  • Volume:
    2,000
  • Bid/Ask:
    0.0300/0.0650
  • Day's Range:
    0.0650 - 0.0650
  • Type:Equity
  • Market:Canada
  • ISIN:CA92941F1053
  • CUSIP:92941F105

WBIO Overview

Prev. Close
0.085
Day's Range
0.065-0.065
Revenue
-
Open
0.065
52 wk Range
0.03-0.44
EPS
-0.04
Volume
2,000
Market Cap
7.37M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
100,257
P/E Ratio
-
Beta
-
1-Year Change
-77.19%
Shares Outstanding
113,438,244
Next Earnings Date
-
What is your sentiment on WPD Pharmaceuticals Inc?
or
Market is currently closed. Voting is open during market hours.

WPD Pharmaceuticals Inc Company Profile

Employees
23
Market
Canada

WPD Pharmaceuticals Inc. engages in the research and development of medicinal products in the fields of oncology and infectious diseases. Its drug development pipeline includes WPD101 to treat brain cancers, including glioblastoma that is in the pre-clinical trial; WPD102 to treat Uval Melanoma, which is in the pre-clinical trial; Berubicin for the treatment of glioblastoma that us in phase 1 clinical trial; and WP1066 to treat central nervous system tumors, pancreatic cancer, and ocular tumors, which is in phase 1 clinical trial. The company’s drug development pipeline also includes WP1732 for the treatment of pancreatic cancer; WP1220 to treat cutaneous T-cell lymphoma; WPD103 for the treatment of glioblastoma multiforme that is in the pre-clinical trial; and Annamycin to treat acute myeloid leukemia (AML) and metastasis to lungs, which is in Phase I/II clinical trials in AML. WPD Pharmaceuticals Inc. is headquartered in Vancouver, Canada.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.